Insights into homeobox B9: a propeller for metastasis in dormant prostate cancer progenitor cells
Open Access
- 10 July 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 125 (7), 1003-1015
- https://doi.org/10.1038/s41416-021-01482-y
Abstract
Background Metastasis is the major cause of treatment failure and cancer-related deaths in prostate cancer (PCa) patients. Our previous study demonstrated that a CD44+ subpopulation isolated from PCa cells or tumours possesses both stem cell properties and metastatic potential, serving as metastatic prostate cancer stem cells (mPCSCs) in PCa metastasis. However, the underlying mechanisms remain unknown. Methods In this study, we established PCa models via the orthotopic and subcutaneous implantation of different human PCa cancer cell lines, and compared the metastatic efficacy, after which process function analysis of target genes was pinpointed. Results Several novel differentially expressed genes (DEGs) between orthotopic and ectopic tumours were identified. Among them, human homeobox B9 (HOXB9) transcription factor was found to be essential for PCa metastasis, as evidenced by the diminished number of lung metastatic foci derived from orthotopic implantation with HOXB9-deficient CWR22 cells, compared with the control. In addition, HOXB9 protein expression was upregulated in PCa tissues, compared with paracancer and benign prostate hyperplasia tissues. It was also positively correlated with Gleason scores. Gain- and loss-of-function assays showed that HOXB9 altered the expression of various tumour metastasis- and cancer stem cell (CSC) growth-related genes in a transforming growth factor beta (TGFβ)-dependent manner. Moreover, HOXB9 was overexpressed in an ALDH+CD44+CXCR4+CD24+ subpopulation of PCa cells that exhibited enhanced TGFβ-dependent tumorigenic and metastatic abilities, compared with other isogenic PCa cells. This suggests that HOXB9 may contribute to PCa tumorigenesis and metastasis via TGFβ signalling. Of note, ALDH+CD44+CXCR4+CD24+-PCa cells exhibited resistance to castration and antiandrogen therapy and were present in human PCa tissues. Conclusion Taken together, our study identified HOXB9 as a critical regulator of metastatic mPCSC behaviour. This occurs through altering the expression of a panel of CSC growth- and invasion/metastasis-related genes via TGFβ signalling. Thus, targeting HOXB9 is a potential novel therapeutic PCa treatment strategy.Keywords
This publication has 48 references indexed in Scilit:
- Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring AmbiguityJournal of Immunology Research, 2012
- The PSA−/lo Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist CastrationCell Stem Cell, 2012
- CXCR4 Expression in Prostate Cancer Progenitor CellsPLOS ONE, 2012
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse modelsProceedings of the National Academy of Sciences of the United States of America, 2010
- Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor ProgressionJournal of Mammary Gland Biology and Neoplasia, 2010
- HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasisProceedings of the National Academy of Sciences of the United States of America, 2009
- WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma MetastasisCell, 2009
- Secondary DNA structure formation for Hoxb9 promoter and identification of its specific binding proteinNucleic Acids Research, 2008
- Multistep Nature of Metastatic Inefficiency: Dormancy of Solitary Cells after Successful Extravasation and Limited Survival of Early MicrometastasesThe American Journal of Pathology, 1998